- Home
- SLDP vs PSTX Comparison
SLDP vs PSTX Comparison
Compare SLDP & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDP
- PSTX
- Stock Information
- Founded
- SLDP 2011
- PSTX 2014
- Country
- SLDP United States
- PSTX United States
- Employees
- SLDP N/A
- PSTX N/A
- Industry
- SLDP Electrical Products
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLDP Energy
- PSTX Health Care
- Exchange
- SLDP Nasdaq
- PSTX Nasdaq
- Market Cap
- SLDP 230.9M
- PSTX 249.1M
- IPO Year
- SLDP N/A
- PSTX 2020
- Fundamental
- Price
- SLDP $1.23
- PSTX $2.50
- Analyst Decision
- SLDP Buy
- PSTX Strong Buy
- Analyst Count
- SLDP 4
- PSTX 2
- Target Price
- SLDP $3.00
- PSTX $15.00
- AVG Volume (30 Days)
- SLDP 1.2M
- PSTX 539.2K
- Earning Date
- SLDP 11-05-2024
- PSTX 11-07-2024
- Dividend Yield
- SLDP N/A
- PSTX N/A
- EPS Growth
- SLDP N/A
- PSTX N/A
- EPS
- SLDP N/A
- PSTX N/A
- Revenue
- SLDP $19,740,000.00
- PSTX $88,462,000.00
- Revenue This Year
- SLDP $15.90
- PSTX $36.53
- Revenue Next Year
- SLDP $117.35
- PSTX N/A
- P/E Ratio
- SLDP N/A
- PSTX N/A
- Revenue Growth
- SLDP 25.66
- PSTX N/A
- 52 Week Low
- SLDP $1.10
- PSTX $1.83
- 52 Week High
- SLDP $2.35
- PSTX $4.27
- Technical
- Relative Strength Index (RSI)
- SLDP 38.65
- PSTX 38.80
- Support Level
- SLDP $1.23
- PSTX $2.41
- Resistance Level
- SLDP $1.28
- PSTX $2.61
- Average True Range (ATR)
- SLDP 0.03
- PSTX 0.11
- MACD
- SLDP 0.00
- PSTX -0.00
- Stochastic Oscillator
- SLDP -6.25
- PSTX 32.14
About SLDP Solid Power Inc.
Solid Power Inc is engaged in developing all-solid-state battery cell technology to enable the next generation of batteries for the EV and other markets. The company's planned business model is to license its all-solid-state battery cell designs and manufacturing know-how to top tier battery manufacturers or automotive original equipment manufacturers and to sell its sulfide-based solid electrolyte for incorporation into all-solid-state battery cells.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.